Bioengineered Corneas from Stem Cells

Photo via Pexels

Future Tech

Curated by Surfaced Editorial·Healthcare·3 min read

Bioengineered corneas from stem cells involve creating artificial corneal tissue in vitro using various types of stem cells, such as limbal stem cells, induced pluripotent stem cells (iPSCs), or mesenchymal stem cells. The goal is to produce a transparent, functionally equivalent cornea that can be transplanted to restore vision. This process often involves culturing cells on biocompatible scaffolds or hydrogels to guide their differentiation into corneal cells, including stromal keratocytes and epithelial cells. Leading research groups include Linköping University in Sweden, the University of Pittsburgh, and institutions in India like LV Prasad Eye Institute. This technology is currently in advanced research and early clinical trials, with several successful human implants of partial corneal constructs. In October 2022, researchers at Linköping University announced successful human implantation of a bioengineered cornea derived from pig collagen, restoring sight to 20 individuals, published in *Nature Biotechnology*. This offers a crucial alternative to donor cornea transplantation, which faces chronic shortages and risk of immune rejection.

Why It Matters

Corneal blindness affects over 12 million people globally, with a severe shortage of donor corneas (only 1 in 7 patients receives a transplant). Bioengineered corneas could provide an unlimited supply of transplantable tissue, offering sight restoration to millions and eliminating the risk of immune rejection if patient-specific cells are used. Blind individuals, eye banks (as suppliers of cells, not whole organs), and ophthalmologists win; traditional cornea procurement organizations might adapt. Challenges include achieving full transparency, long-term stability, and integration with the host eye's nerves and blood supply, alongside rigorous regulatory testing for safety and efficacy. Initial human trials are ongoing, with widespread clinical availability for simpler cases within 5-10 years, and complex full-thickness corneas in 10-15 years. Sweden, India, and the US are key players in this specific regenerative medicine area. A second-order consequence is the potential for 'vision tourism,' where individuals travel to specific countries for access to these advanced, potentially elective, sight-restoring procedures.

Development Stage

Early Research

Advanced Research

Prototype

Early Commercialization

Growth Phase

f in r/✉

←In Situ Bioprinting for Wound Healing Microfluidic-based Vascular Network Bioprinting→

From Discovery · Product · Tool · Hidden Gem

Discovery

CRISPR-Cas9: A Revolutionary Tool for Precision Gene Editing

CRISPR-Cas9 is a groundbreaking gene-editing technology that allows scientists to precisely cut and paste DNA sequences, effectively correcting genetic 'typos'…

Product

Anker PowerCore III Elite 25600 60W

The Anker PowerCore III Elite 25600 60W is a high-capacity portable power bank designed to keep all your devices charged, from smartphones to laptops, while on…

Tool

Diigo

Diigo, developed by Diigo, Inc., is a powerful social bookmarking and web annotation tool that allows users to save, highlight, and add sticky notes to web…

Hidden Gem

Scrintal

Scrintal is a visual knowledge canvas and note-taking tool developed by a startup, designed to help users think spatially and connect ideas on an infinite…